Osaic Holdings
FDMT icon

Osaic Holdings’s 4D Molecular Therapeutics FDMT Stock Holding History

Osaic Holdings’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$493 Buy
53
+31
+141% +$270 ﹤0.01% 7442
2025
Q4 		$165 Buy
22
+17
+340% +$172 ﹤0.01% 7598
2025
Q3 		$43 Sell
5
-5
-50% -$30 ﹤0.01% 7791
2025
Q2 		$38 Buy
10
+5
+100% +$18 ﹤0.01% 7630
2025
Q1 		$16 Sell
5
-63
-93% -$297 ﹤0.01% 7359
2024
Q4 		$379 Sell
68
-17,609
-100% -$138K ﹤0.01% 7074
2024
Q3 		$191K Buy
17,677
+17,542
+12,994% +$291K ﹤0.01% 3680
2024
Q2 		$2.83K Buy
+135
New +$3.39K ﹤0.01% 6458
2024
Q1 		– Sell
-1,575
Closed -$31.9K – 7260
2023
Q4 		$31.9K Hold
1,575
– – ﹤0.01% 5196
2023
Q3 		$20.1K Hold
1,575
– – ﹤0.01% 5553
2023
Q2 		$28.5K Sell
1,575
-211
-12% -$3.88K ﹤0.01% 5326
2023
Q1 		$30.7K Buy
1,786
+87
+5% +$1.69K ﹤0.01% 5304
2022
Q4 		$38K Sell
1,699
-4,020
-70% -$62.1K ﹤0.01% 5131
2022
Q3 		$46K Hold
5,719
– – ﹤0.01% 4974
2022
Q2 		$40K Hold
5,719
– – ﹤0.01% 5117
2022
Q1 		$86K Sell
5,719
-167
-3% -$2.62K ﹤0.01% 4701
2021
Q4 		$129K Buy
5,886
+11
+0.2% +$270 ﹤0.01% 4349
2021
Q3 		$158K Hold
5,875
– – ﹤0.01% 4114
2021
Q2 		$141K Buy
+5,875
New +$180K ﹤0.01% 4190

Other funds holding FDMT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Osaic Holdings's FDMT Position: Q1 2026 in Review

Osaic Holdings increased its 4D Molecular Therapeutics (FDMT) stake by 141% in Q1 2026, buying an estimated $270 and bringing the position to 53 shares worth $493. The position accounts for ﹤0.01% of the portfolio, ranked #7442.

Osaic Holdings first reported a position in FDMT in Q2 2021 and has held it in 19 quarters since. The position peaked at $191K in Q3 2024. 152 funds tracked by Wall St. Rank hold FDMT as of Q1 2026.

  • Osaic Holdings held 53 shares of 4D Molecular Therapeutics worth $493 as of Q1 2026.
  • Osaic Holdings bought 31 4D Molecular Therapeutics shares in Q1 2026, an estimated $270.
  • 4D Molecular Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7442 holding.
  • Osaic Holdings first reported a position in 4D Molecular Therapeutics in Q2 2021 and has held it in 19 quarters since.
  • Osaic Holdings's 4D Molecular Therapeutics position peaked at $191K in Q3 2024.
  • 152 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.